venetoclax,ibrutinib
roche,abbvie,Janssen
['captivate', 'lymsm', 'lymphoma', 'abbvie']
congress| #eha2022 lisa j. croner, reports on resistance mutations at the time of pd in pts treated with fixed-duration i+v in the captivate trial, highlighting that no resistance mutations in btk, plcg2, or bcl2 were identified #lymphoma #lymsm #medicalcongress 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm